Wang, Menglin http://orcid.org/0000-0002-5348-5983
Rousseau, Benoit http://orcid.org/0000-0002-1594-4827
Qiu, Kunyu
Huang, Guannan
Zhang, Yu
Su, Hang
Le Bihan-Benjamin, Christine
Khati, Ines
Artz, Oliver http://orcid.org/0000-0002-5708-1281
Foote, Michael B. http://orcid.org/0000-0003-3027-2405
Cheng, Yung-Yi http://orcid.org/0000-0001-7473-2835
Lee, Kuo-Hsiung
Miao, Michael Z.
Sun, Yue
Bousquet, Philippe-Jean http://orcid.org/0000-0002-0217-5483
Hilmi, Marc
Dumas, Elise
Hamy, Anne-Sophie
Reyal, Fabien
Lin, Lin
Armistead, Paul M.
Song, Wantong
Vargason, Ava
Arthur, Janelle C. http://orcid.org/0000-0002-4796-0207
Liu, Yun
Guo, Jianfeng http://orcid.org/0000-0002-2893-912X
Zhou, Xuefei
Nguyen, Juliane
He, Yongqun http://orcid.org/0000-0001-9189-9661
Ting, Jenny P.-Y.
Anselmo, Aaron C.
Huang, Leaf http://orcid.org/0000-0002-9421-8283
Funding for this research was provided by:
UNC | UNC-Chapel Hill | UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill (Fred Eshelman Distinguished Professorship)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (CA198999, P30 CA008748, P30 CA008748, P30 CA008748, T32 CA009512, CA198999)
American Society of Clinical Oncology (Young Investigator Award)
Article History
Received: 4 May 2022
Accepted: 18 August 2023
First Online: 25 September 2023
Competing interests
: L. Huang: Consultant with PDS Biotechnology and Stemirna Therapeutics. B. Rousseau: Advisory/Consultancy, Speaker Bureau/Expert testimony: Bayer; Advisory/Consultancy, Speaker Bureau/Expert testimony: Roche; Travel/Accommodation/Expenses: Servier; Travel/Accommodation/Expenses: Astellas; Speaker Bureau/Expert testimony: Gilead.